ES
Enavate Sciences Portfolio holdings
AUM
$177M
This Quarter Return
-34.78%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$139M
AUM Growth
–
Cap. Flow
+$139M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
UPB
Upstream Bio, Inc. Common Stock
UPB
|
$40.4M |
| 2 |
Immunome
IMNM
|
$36.9M |
| 3 |
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
|
$30.8M |
| 4 |
CAMP4 Therapeutics Corporation Common Stock
CAMP
|
$19.8M |
| 5 |
Compass Therapeutics
CMPX
|
$11.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UPB
1
Upstream Bio, Inc. Common Stock
UPB
$923M
| $40.4M | 29.04% |
+2,459,703
| New | +$40.4M |
|
|
2
Immunome
IMNM
$828M
| $36.9M | 26.53% |
+3,478,261
| New | +$36.9M |
|
|
ZBIO
3
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $30.8M | 22.12% |
+3,761,359
| New | +$30.8M |
|
|
4
CAMP4 Therapeutics Corporation Common Stock
CAMP
$30.6M
| $19.8M | 14.19% |
+3,785,802
| New | +$19.8M |
|
|
5
Compass Therapeutics
CMPX
$483M
| $11.3M | 8.11% |
+7,788,150
| New | +$11.3M |
|